GAFFX
Price
$76.83
Change
+$0.89 (+1.17%)
Updated
Dec 24 closing price
MFEKX
Price
$211.05
Change
+$2.66 (+1.28%)
Updated
Dec 24 closing price
Ad is loading...

GAFFX vs MFEKX

Header iconGAFFX vs MFEKX Comparison
Open Charts GAFFX vs MFEKXBanner chart's image
American Funds Growth Fund of Amer F3
Price$76.83
Change+$0.89 (+1.17%)
VolumeN/A
CapitalizationN/A
MFS Growth R6
Price$211.05
Change+$2.66 (+1.28%)
VolumeN/A
CapitalizationN/A
GAFFX vs MFEKX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. MFEKX commentary
Dec 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a Buy and MFEKX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 307B vs. MFEKX (48.6B). GAFFX pays higher dividends than MFEKX: GAFFX (0.75) vs MFEKX (0.00). GAFFX was incepted earlier than MFEKX: GAFFX (8 years) vs MFEKX (13 years). GAFFX is a more actively managed with annual turnover of: 31.00 vs. MFEKX (25.00). MFEKX has a lower initial minimum investment than GAFFX: MFEKX (0) vs GAFFX (1000000). GAFFX (22.68) and MFEKX (22.15) have marching annual gain over last year. MFEKX return over 5 years is better than : 64.55 vs. GAFFX (52.27).
GAFFXMFEKXGAFFX / MFEKX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years13 years-
Gain YTD22.44921.857103%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets307B48.6B632%
Annual Yield % from dividends0.750.00-
Returns for 1 year22.6822.15102%
Returns for 3 years4.858.2159%
Returns for 5 years52.2764.5581%
Returns for 10 yearsN/A192.43-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VNDA4.830.15
+3.21%
Vanda Pharmaceuticals
TISI15.290.31
+2.07%
Team
ARLO11.540.15
+1.32%
Arlo Technologies
CVE14.710.05
+0.34%
Cenovus Energy
KRYS158.52-2.31
-1.44%
Krystal Biotech